Prenatal effects of maternal consumption of polyphenol-rich foods in late pregnancy upon fetal ductus arteriosus

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 99, Issue 4, 2013, Pages 256-274

  Zielinsky, Paulo ^a   Busato, Stefano ^a  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

Author keywords

Antiinflammatory substances; Ductal constriction; Polyphenols; Prostaglandins; Pulmonary hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ARACHIDONIC ACID; CATECHIN; CHLOROGENIC ACID; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPYRONE; EPICATECHIN GALLATE; EPIGALLOCATECHIN; FLAVONOID; GALLATE 3 EPICATECHIN; GALLATE 3 EPIGALLOCATECHIN; GLUCOCORTICOID; IBUPROFEN; INDOMETACIN; KAEMPFEROL; NIMESULIDE; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; POLYPHENOL; PROSTAGLANDIN; QUERCETIN; RESVERATROL; RETINOIC ACID; ROFECOXIB; SULINDAC; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANGIOGENESIS; ARTERY BLOOD FLOW; ARTERY CONSTRICTION; BIOLOGICAL ACTIVITY; BLOOD FLOWMETRY; BLOOD VESSEL FUNCTION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DUCTUS ARTERIOSUS; FETUS CIRCULATION; FOOD COMPOSITION; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; GRAPE JUICE; HERBAL TEA; HUMAN; IDIOPATHIC DISEASE; INFLAMMATION; INHIBITION KINETICS; MATE TEA; MATERNAL NUTRITION; NONHUMAN; OPEN STUDY; OXIDATIVE STRESS; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PREGNANT WOMAN; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGISTER; REVIEW; TEA; THIRD TRIMESTER PREGNANCY; URINARY EXCRETION;

ANTIINFLAMMATORY SUBSTANCES; DUCTAL CONSTRICTION; POLYPHENOLS; PROSTAGLANDINS; PULMONARY HYPERTENSION;

CONSTRICTION; DIET; DUCTUS ARTERIOSUS; FEMALE; FETUS; HUMANS; INDOMETHACIN; MATERNAL EXPOSURE; POLYPHENOLS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PRENATAL EXPOSURE DELAYED EFFECTS; PROSTAGLANDIN ANTAGONISTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84890407023     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.21051     Document Type: Review

References (180)

1. Abdel Mohsen AH, Amin AS. 2013. Risk factors and outcomes of persistent pulmonary hypertension of the newborn in neonatal intensive care unit of Al-minya university hospital in egypt. J Clin Neonatol 2:78-82.
2. Abman SH. 1999. Abnormal vasoreactivity in the pathophysiology of persistent pulmonary hypertension of the newborn. Pediatr Rev 20:e103-109.
3. Adibe OO, St. Peter SD. 2012. Equipoise, ethics, and the necessity of randomized trials in surgery. Arch Surg 147:899-900.
4. Akkol EK, Das S, Sarker SD, Nahar L. 2012. The treatment of inflammation, pain, and Fever using medicinal plants. Adv Pharmacol Sci 2012:476985.
5. Alano MA, Ngougmna E, Ostrea EM Jr, Konduri GG. 2001. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics 107:519-523.
6. Andrade JP, Assuncao M. 2012. Protective effects of chronic green tea consumption on age-related neurodegeneration. Curr Pharm Des 18:4-14.
7. Andujar I, Recio MC, Giner RM, Rios JL. 2012. Cocoa polyphenols and their potential benefits for human health. Oxid Med Cell Longev 2012:906252.
8. Auer M, Brezinka C, Eller P, et al. 2004. Prenatal diagnosis of intrauterine premature closure of the ductus arteriosus following maternal diclofenac application. Ultrasound Obstet Gynecol 23:513-516.
9. Azancot-Benisty A, Benifla JL, Matias A, et al. 1995. Constriction of the fetal ductus arteriosus during prenatal betamethasone therapy. Obstet Gynecol 85(5 Pt 2):874-876.
10. Babaoglu K, Cakiroglu Y, Altun G, et al. 2013. Intrauterine idiopathic severe ductal constriction diagnosed by fetal echocardiography: a cause of hydrops fetalis. Anadolu Kardiyol Derg 13:496-497.
11. Backhouse N, Delporte C, Givernau M, et al. 1994. Anti-inflammatory and antipyretic effects of boldine. Agents Actions 42:114-117.
12. Baragatti B, Ciofini E, Scebba F, et al. 2011. Cytochrome P-450 3A13 and endothelin jointly mediate ductus arteriosus constriction to oxygen in mice. Am J Physiol Heart Circ Physiol 300:H892-901.
13. Bergwerff M, DeRuiter MC, Gittenberger-de Groot AC. 1999. Comparative anatomy and ontogeny of the ductus arteriosus, a vascular outsider. Anat Embryol (Berl) 200:559-571.
14. Besinger RE, Niebyl JR, Keyes WG, Johnson TR. 1991. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol 164:981-986; discussion 986-988.
15. Bixby M, Spieler L, Menini T, Gugliucci A. 2005. Ilex paraguariensis extracts are potent inhibitors of nitrosative stress: a comparative study with green tea and wines using a protein nitration model and mammalian cell cytotoxicity. Life Sci 77:345-358.
16. Bozin B, Mimica-Dukic N, Samojlik I, Jovin E. 2007. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J Agric Food Chem 55:7879-7885.
17. Bravo L. 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56:317-333.
18. Brezinka C, Gittenberger-de Groot AC, Wladimiroff JW. 1993. The fetal ductus arteriosus, a review. Zentralbl Gynakol 115:423-432.
19. Bubols G, Zielinsky P, Piccoli A Jr, et al. Inflammation and oxidative stress are involved in the polyphenol-induced ductus arteriosus constriction in pregnant sheep (in press).
20. Cassin S, Tyler T, Leffler C, Wallis R. 1979. Pulmonary and systemic vascular responses of perinatal goats to prostaglandins E1 and E2. Am J Physiol 236:H828-832.
21. Celik I, Isik I. 2008. Determination of chemopreventive role of Foeniculum vulgare and Salvia officinalis infusion on trichloroacetic acid-induced increased serum marker enzymes lipid peroxidation and antioxidative defense systems in rats. Nat Prod Res 22:66-75.
22. Chen B, Tuuli MG, Longtine MS, et al. 2012a. Pomegranate juice and punicalagin attenuate oxidative stress and apoptosis in human placenta and in human placental trophoblasts. Am J Physiol Endocrinol Metab 302:E1142-1152.
23. Chen JX, O'Mara PW, Poole SD, et al. 2012b. Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus. Pediatr Res 72:122-128.
24. Chen PC, Wheeler DS, Malhotra V, et al. 2002. A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IkappaB kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation 26:233-241.
25. Chun OK, Kim DO, Lee CY. 2003. Superoxide radical scavenging activity of the major polyphenols in fresh plums. J Agric Food Chem 51:8067-8072.
26. Clyman RI, Ballard PL, Sniderman S, et al. 1981a. Prenatal administration of betamethasone for prevention of patient ductus arteriosus. J Pediatr 98:123-126.
27. Clyman RI, Mauray F, Roman C, et al. 1981b. Glucocorticoids alter the sensitivity of the lamb ductus arteriosus to prostaglandin E2. J Pediatr 98:126-128.
28. Coceani F. 1993. Control mechanisms for the ductus arteriosus and the perinatal pulmonary circulation. J Lipid Mediat 6:473-476.
29. Coceani F. 2013. Oxygen sensing in the ductus arteriosus: endothelin still a player. Circ Res 112:e154.
30. Coceani F, Baragatti B. 2012. Mechanisms for ductus arteriosus closure. Semin Perinatol 36:92-97.
31. Coceani F, Liu YA, Seidlitz E, et al. 2000. Deletion of the endothelin-A-receptor suppresses oxygen-induced constriction but not postnatal closure of the ductus arteriosus. J Cardiovasc Pharmacol 36(5 Suppl 1):S75-77.
32. Cooper CL, Malik KU. 1984. Effect of glucocorticoids on vascular reactivity to vasoactive hormones in rat isolated kidney: lack of relationship to prostaglandins. Br J Pharmacol 82:679-688.
33. Csaba IF, Sulyok E, Ertl T. 1978. Relationship of maternal treatment with indomethacin to persistence of fetal circulation syndrome. J Pediatr 92:484.
34. D'Argenio G, Mazzone G, Tuccillo C. 2008. Apple polyphenol extracts prevent aspirin-induced damage to the rat gastric mucosa. Br J Nutr 100:1228-1236.
35. de Reeder EG, Gittenberger-de Groot AC, van Munsteren JC. 1989. Distribution of prostacyclin synthase, 6-keto-prostaglandin F1 alpha, and 15-hydroxy-prostaglandin dehydrogenase in the normal and persistent ductus arteriosus of the dog. Am J Pathol 135:881-887.
36. Della Loggia R, Tubaro A, Dri P. 1986. The role of flavonoids in the antiinflammatory activity of Chamomilla recutita. Prog Clin Biol Res 213:481-484.
37. di Giuseppe R, Di Castelnuovo A, Centritto F, et al. 2008. Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population. J Nutr 138:1939-1945.
38. Di Paola R, Mazzon E, Muia C, et al. 2005. Green tea polyphenol extract attenuates lung injury in experimental model of carrageenan-induced pleurisy in mice. Respir Res 6:66.
39. Dudley DK, Hardie MJ. 1985. Fetal and neonatal effects of indomethacin used as a tocolytic agent. Am J Obstet Gynecol 151:181-184.
40. Duffy SJ, Keaney JF Jr, Holbrook M, et al. 2001a. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104:151-156.
41. Duffy SJ, Vita JA, Holbrook M, et al. 2001b. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21:1084-1089.
42. Enzensberger C, Wienhard J, Weichert J, et al. 2012. Idiopathic constriction of the fetal ductus arteriosus: three cases and review of the literature. J Ultrasound Med 31:1285-1291.
43. Eronen M. 1993. The hemodynamic effects of antenatal indomethacin and a beta-sympathomimetic agent on the fetus and the newborn: a randomized study. Pediatr Res 33:615-619.
44. Eronen M, Pesonen E, Kurki T, et al. 1991. The effects of indomethacin and a beta-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study. Am J Obstet Gynecol 164(1 Pt 1):141-146.
45. Fan F, Ma A, Guan Y, et al. 2011. Effect of PGE2 on DA tone by EP4 modulating Kv channels with different oxygen tension between preterm and term. Int J Cardiol 147:58-65.
46. Freedman B. 1987. Equipoise and the ethics of clinical research. N Engl J Med 317:141-145.
47. Fukumoto LR, Mazza G. 2000. Assessing antioxidant and prooxidant activities of phenolic compounds. J Agric Food Chem 48:3597-3604.
48. Fyfe DA, Kline CH. 1990. Fetal echocardiographic diagnosis of congenital heart disease. Pediatr Clin North Am 37:45-67.
49. Gifford F. 2007. Pulling the plug on clinical equipoise: a critique of Miller and Weijer. Kennedy Inst Ethics J 17:203-226; discussion 227-246.
50. Gordon MC, Samuels P. 1995. Indomethacin. Clin Obstet Gynecol 38:697-705.
51. Goudie BM, Dossetor JF. 1979. Effect on the fetus of indomethacin given to suppress labour. Lancet 2:1187-1188.
52. Hadi SM, Bhat SH, Azmi AS, et al. 2007. Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties. Semin Cancer Biol 17:370-376.
53. Hallak M, Reiter AA, Ayres NA, Moise KJ Jr. 1991. Indomethacin for preterm labor: fetal toxicity in a dizygotic twin gestation. Obstet Gynecol 78(5 Pt 2):911-913.
54. Harada K, Rice MJ, McDonald RW, et al. 1997a. Doppler echocardiographic evaluation of ventricular diastolic filling in fetuses with ductal constriction. Am J Cardiol 79:442-446.
55. Harada K, Rice MJ, Shiota T, et al. 1997b. Two-dimensional echocardiographic evaluation of ventricular systolic function in human fetuses with ductal constriction. Ultrasound Obstet Gynecol 10:247-253.
56. Harlass FE, Duff P, Brady K, Read J. 1989. Hydrops fetalis and premature closure of the ductus arteriosus: a review. Obstet Gynecol Surv 44:541-543.
57. Hassid A. 1982. Regulation of prostaglandin biosynthesis in cultured cells. Am J Physiol 243:C205-211.
58. Heijnen CG, Haenen GR, Vekemans JA, Bast A. 2001. Peroxynitrite scavenging of flavonoids: structure activity relationship. Environ Toxicol Pharmacol 10:199-206.
59. Hellman S, Hellman DS. 1991. Of mice but not men. Problems of the randomized clinical trial. N Engl J Med 324:1585-1589.
60. Hernández-Díaz S, Van Marter L, Werler MM, et al. 2007. Risk factors for persistent pulmonary hypertension of the newborn. Pedatrics 120:e272-e282.
61. Heymann MA, Rudolph AM. 1975. Control of the ductus arteriosus. Physiol Rev 55:62-78.
62. Heymann MA, Rudolph AM. 1976. Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero. Circ Res 38:418-422.
63. Ho SY, Anderson RH. 1979. Anatomical closure of the ductus arteriosus: a study in 35 specimens. J Anat 128(Pt 4):829-836.
64. Hodgson JM, Croft KD, Woodman RJ, et al. 2013a. Black tea lowers the rate of blood pressure variation: a randomized controlled trial. Am J Clin Nutr 97:943-950.
65. Hodgson JM, Woodman RJ, Puddey IB, et al. 2013b. Short-term effects of polyphenol-rich black tea on blood pressure in men and women. Food Funct 4:111-115.
66. Hofstadler G, Tulzer G, Altmann R, et al. 1996. Spontaneous closure of the human fetal ductus arteriosus-a cause of fetal congestive heart failure. Am J Obstet Gynecol 174:879-883.
67. Hong Z, Kutty S, Toth PT, et al. 2013. Role of dynamin-related protein 1 (Drp1)-mediated mitochondrial fission in oxygen sensing and constriction of the ductus arteriosus. Circ Res 112:802-815.
68. Hsu JH, Oishi P, Wiseman DA, et al. 2010. Nitric oxide alterations following acute ductal constriction in the fetal lamb: a role for superoxide. Am J Physiol Lung Cell Mol Physiol 298:L880-887.
69. Huhta JC, Moise KJ, Fisher DJ, et al. 1987. Detection and quantitation of constriction of the fetal ductus arteriosus by Doppler echocardiography. Circulation 75:406-412.
70. Ichikawa Y, Yokoyama U, Iwamoto M, et al. 2012. Inhibition of phosphodiesterase type 3 dilates the rat ductus arteriosus without inducing intimal thickening. Circ J 76:2456-2464.
71. Ito H, Gonthier MP, Manach C, et al. 2005. Polyphenol levels in human urine after intake of six different polyphenol-rich beverages. Br J Nutr 94:500-509.
72. Jin UH, Park SG, Suh SJ, et al. 2007. Inhibitory effect of Panax notoginseng on nitric oxide synthase, cyclo-oxygenase-2 and neutrophil functions. Phytother Res 21:142-148.
73. Joffe S, Miller FG. 2012. Equipoise: asking the right questions for clinical trial design. Nat Rev Clin Oncol 9:230-235.
74. Kajimoto H, Hashimoto K, Bonnet SN, et al. 2007. Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction. Circulation 115:1777-1788.
75. Kapadia V, Embers D, Wells E, et al. 2010. Prenatal closure of the ductus arteriosus and maternal ingestion of anthocyanins. J Perinatol 30:291-294.
76. Karadas B, Kaya T, Bagcivan I, et al. 2004. Comparison of effects of cyclooxygenase inhibitors on myometrial contraction and constriction of ductus arteriosus in rats. Eur J Pharmacol 485:289-298.
77. Keller RL, Tacy TA, Fields S, et al. 2005. Combined treatment with a nonselective nitric oxide synthase inhibitor (l-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. Pediatr Res 58:1216-1221.
78. Khan HY, Zubair H, Ullah MF, et al. 2012. A prooxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols. Curr Drug Targets 13:1738-1749.
79. Khayyal MT, el-Ghazaly MA, el-Khatib AS, A et al. 2003. A clinical pharmacological study of the potential beneficial effects of a propolis food product as an adjuvant in asthmatic patients. Fundam Clin Pharmacol 17:93-102.
80. Koren G, Florescu A, Costei AM, et al. 2006. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother 40:824-829.
81. Kris-Etherton PM, Hecker KD, Bonanome A, et al. 2002. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 113 (Suppl 9B):71S-88S.
82. Kupeli E, Tatli II, Akdemir ZS, Yesilada E. 2007a. Bioassay-guided isolation of anti-inflammatory and antinociceptive glycoterpenoids from the flowers of Verbascum lasianthum Boiss. ex Bentham. J Ethnopharmacol 110:444-450.
83. Kupeli E, Tatli II, Akdemir ZS, Yesilada E. 2007b. Estimation of antinociceptive and anti-inflammatory activity on Geranium pratense subsp. finitimum and its phenolic compounds. J Ethnopharmacol 114:234-240.
84. Levin DL, Fixler DE, Morriss FC, Tyson J. 1978a. Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors. J Pediatr 92:478-483.
85. Levin DL, Hyman AI, Heymann MA, Rudolph AM. 1978b. Fetal hypertension and the development of increased pulmonary vascular smooth muscle: a possible mechanism for persistent pulmonary hypertension of the newborn infant. J Pediatr 92:265-269.
86. Levin DL, Mills LJ, Weinberg AG. 1979. Hemodynamic, pulmonary vascular, and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus. A possible mechanism for persistent pulmonary hypertension and transient tricuspid insufficiency in the newborn infant. Circulation 60:360-364.
87. Levin DL, Rudolph AM, Heymann MA, Phibbs RH. 1976. Morphological development of the pulmonary vascular bed in fetal lambs. Circulation 53:144-151.
88. Levin M, Goldbarg S, Lindqvist A, et al. 2005. ATP depletion and cell death in the neonatal lamb ductus arteriosus. Pediatr Res 57:801-805.
89. Levy R, Matitiau A, Ben Arie A, et al. 1999. Indomethacin and corticosteroids: an additive constrictive effect on the fetal ductus arteriosus. Am J Perinatol 16:379-383.
90. Lock JE, Olley PM, Soldin S, Coceani F. 1980. Indomethacin-induced pulmonary vasoconstriction in the conscious newborn lamb. Am J Physiol 238:H639-651.
91. Lorenzi H, Matos FJ. 2002. Plantas medicinais no Brasil: nativas e exóticas. Nova Odessa: Instituto Planturum 512.
92. Macones GA, Robinson CA. 1997. Is there justification for using indomethacin in preterm labor? An analysis of neonatal risks and benefits. Am J Obstet Gynecol 177:819-824.
93. Majed BH, Khalil RA. 2012. Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacol Rev 64:540-582.
94. Majewska M, Skrzycki M, Podsiad M, Czeczot H. 2011. Evaluation of antioxidant potential of flavonoids: an in vitro study. Acta Pol Pharm 68:611-615.
95. Malik A, Azam S, Hadi N, Hadi SM. 2003. DNA degradation by water extract of green tea in the presence of copper ions: implications for anticancer properties. Phytother Res 17:358-363.
96. Manchester D, Margolis HS, Sheldon RE. 1976. Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn. Am J Obstet Gynecol 126:467-469.
97. Mari G, Moise KJ Jr, Deter RL, et al. 1989. Doppler assessment of the pulsatility index of the middle cerebral artery during constriction of the fetal ductus arteriosus after indomethacin therapy. Am J Obstet Gynecol 161(6 Pt 1):1528-1531.
98. Martinez J, Moreno JJ. 2000. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 59:865-870.
99. Mathew AS, Capel-Williams GM, Berry SE, Hall WL. 2012. Acute effects of pomegranate extract on postprandial lipaemia, vascular function and blood pressure. Plant Foods Hum Nutr 67:351-357.
100. Michelakis ED, Thebaud B, Weir EK, Archer SL. 2004. Hypoxic pulmonary vasoconstriction: redox regulation of O2-sensitive K+ channels by a mitochondrial O2-sensor in resistance artery smooth muscle cells. J Mol Cell Cardiol 37:1119-1136.
101. Mielke G, Benda N. 2000. Reference ranges for two-dimensional echocardiographic examination of the fetal ductus arteriosus. Ultrasound Obstet Gynecol 15:219-225.
102. Moise KJ Jr. 1993. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am J Obstet Gynecol 168:1350-1353.
103. Moise KJ Jr, Huhta JC, Sharif DS, et al. 1988. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med 319:327-331.
104. Moise KJ Jr, Ou CN, Kirshon B, et al. 1990. Placental transfer of indomethacin in the human pregnancy. Am J Obstet Gynecol 162:549-554.
105. Momma K, Ando M. 1994. In situ morphology of fetal aortic isthmus following ductal constriction in rats. Fetal Diagn Ther 9:53-61.
106. Momma K, Hagiwara H, Konishi T. 1984. Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs:study of additional 34 drugs. Prostaglandins 28:527-536.
107. Momma K, Nakanishi T, Imamura S. 2003. Inhibition of in vivo constriction of fetal ductus arteriosus by endothelin receptor blockade in rats. Pediatr Res 53:479-485.
108. Momma K, Nishihara S, Ota Y. 1981. Constriction of the fetal ductus arteriosus by glucocorticoid hormones. Pediatr Res 15:19-21.
109. Momma K, Toyoshima K, Takeuchi D, et al. 2005. In vivo constriction of the fetal and neonatal ductus arteriosus by a prostanoid EP4-receptor antagonist in rats. Pediatr Res 58:971-975.
110. Montanher AB, Zucolotto SM, Schenkel EP, Frode TS. 2007. Evidence of anti-inflammatory effects of Passiflora edulis in an inflammation model. J Ethnopharmacol 109:281-288.
111. Mori Y, Rice MJ, McDonald RW, et al. 2001. Evaluation of systolic and diastolic ventricular performance of the right ventricle in fetuses with ductal constriction using the Doppler Tei index. Am J Cardiol 88:1173-1178.
112. Murphy JD, Rabinovitch M, Goldstein JD, Reid LM. 1981. The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr 98:962-967.
113. Murphy JD, Vawter GF, Reid LM. 1984. Pulmonary vascular disease in fatal meconium aspiration. J Pediatr 104:758-762.
114. Mushiake K, Motoyoshi F, Kinoshita Y, et al. 2002. Severe heart failure due to ductal constriction caused by maternal indomethacin. Pediatr Int 44:174-176.
115. Nijveldt RJ, van Nood E, van Hoorn DE, et al. 2001. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418-425.
116. Norton ME. 1997. Teratogen update: fetal effects of indomethacin administration during pregnancy. Teratology 56:282-292.
117. Norton ME, Merrill J, Cooper BA, et al. 1993. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 329:1602-1607.
118. Obladen M. 2011. History of the ductus arteriosus: 1. Anatomy and spontaneous closure. Neonatology 99:83-89.
119. Paladini D, Marasini M, Volpe P. 2005. Severe ductal constriction in the third-trimester fetus following maternal self-medication with nimesulide. Ultrasound Obstet Gynecol 25:357-361.
120. Petticrew M, McKee M, Lock K, et al. 2013. In search of social equipoise. BMJ 347:f4016.
121. Pozharitskaya ON, Ivanova SA, Shikov AN, Makarov VG. 2007a. Separation and evaluation of free radical-scavenging activity of phenol components of Emblica officinalis extract by using an HPTLC-DPPH* method. J Sep Sci 30:1250-1254.
122. Pozharitskaya ON, Ivanova SA, Shikov AN, et al. 2007b. Separation and evaluation of free radical-scavenging activity of phenol components of green, brown, and black leaves of Bergenia crassifolia by using HPTLC-DPPH* method. J Sep Sci 30:2447-2451.
123. Rasanen J, Jouppila P. 1995. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. Am J Obstet Gynecol 173:20-25.
124. Reese J, O'Mara PW, Poole SD, et al. 2009. Regulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall. Prostaglandins Other Lipid Mediat 88:89-96.
125. Respondek M, Weil SR, Huhta JC. 1995. Fetal echocardiography during indomethacin treatment. Ultrasound Obstet Gynecol 5:86-89.
126. Romain C, Gaillet S, Carillon J, et al. 2012. Vineatrol and cardiovascular disease: beneficial effects of a vine-shoot phenolic extract in a hamster atherosclerosis model. J Agric Food Chem 60:11029-11036.
127. Rubaltelli FF, Chiozza ML, Zanardo V, Cantarutti F. 1979. Effect on neonate of maternal treatment with indomethacin. J Pediatr 94:161.
128. Rudolph AM. 1981. The effects of nonsteroidal antiinflammatory compounds on fetal circulation and pulmonary function. Obstet Gynecol 58(5 Suppl):63S-67S.
129. Scalbert A, Williamson G. 2000. Dietary intake and bioavailability of polyphenols. J Nutr 130(8S Suppl):2073S-2085S.
130. Schiessl B, Schneider KT, Zimmermann A, et al. 2005. Prenatal constriction of the fetal ductus arteriosus-related to maternal pain medication? Z Geburtshilfe Neonatol 209:65-68.
131. Selmi C, Cocchi CA, Lanfredini M, et al. 2008. Chocolate at heart: the anti-inflammatory impact of cocoa flavanols. Mol Nutr Food Res 52:1340-1348.
132. Sharpe GL, Larsson KS, Thalme B. 1975. Studies on closure of the ductus arteriosus. XII. In utero effect of indomethacin and sodium salicylate in rats and rabbits. Prostaglandins 9:585-596.
133. Sheehan M, Timlin C, Peach K, et al. 2013. Position statement on ethics, equipoise and research on charged particle radiation therapy. J Med Ethics (Epub ahead of print).
134. Shima Y, Ishikawa H, Matsumura Y, et al. 2011. Idiopathic severe constriction of the fetal ductus arteriosus: a possible underestimated pathophysiology. Eur J Pediatr 170:237-240.
135. Silva JR, Campos AC, Ferreira LM, et al. 2006. [Extract of Passiflora edulis in the healing process of gastric sutures in rats: a morphological and tensiometric study]. Acta Cir Bras 21 (Suppl 2):52-60.
136. Slomp J, Gittenberger-de Groot AC, Glukhova MA, et al. 1997. Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler Thromb Vasc Biol 17:1003-1009.
137. Slomp J, van Munsteren JC, Poelmann RE, et al. 1992. Formation of intimal cushions in the ductus arteriosus as a model for vascular intimal thickening. An immunohistochemical study of changes in extracellular matrix components. Atherosclerosis 93:25-39.
138. Smith DM, Dou QP. 2001. Green tea polyphenol epigallocatechin inhibits DNA replication and consequently induces leukemia cell apoptosis. Int J Mol Med 7:645-652.
139. Sridharan S, Archer N, Manning N. 2009. Premature constriction of the fetal ductus arteriosus following the maternal consumption of camomile herbal tea. Ultrasound Obstet Gynecol 34:358-359.
140. Starling MB, Elliott RB. 1974. The effects of prostaglandins, prostaglandin inhibitors, and oxygen on the closure of the ductus arteriosus, pulmonary arteries and umbilical vessels in vitro. Prostaglandins 8:187-203.
141. Stoller JZ, Demauro SB, Dagle JM, Reese J. 2012. Current perspectives on pathobiology of the ductus arteriosus. J Clin Exp Cardiolog 8:pii:S8-001.
142. Subbaramaiah K, Chung WJ, Michaluart P, et al. 1998. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273:21875-21882.
143. Tada T, Wakabayashi T, Nakao Y, et al. 1985. Human ductus arteriosus. A histological study on the relation between ductal maturation and gestational age. Acta Pathol Jpn 35:23-34.
144. Takahashi Y, Roman C, Chemtob S, et al. 2000. Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo. Am J Physiol Regul Integr Comp Physiol 278:R1496-1505.
145. Takami T, Momma K, Imamura S. 2005. Increased constriction of the ductus arteriosus by dexamethasone, indomethacin, and rofecoxib in fetal rats. Circ J 69:354-358.
146. Takizawa T, Horikoshi E, Shen MH, et al. 2000. Effects of TAK-044, a nonselective endothelin receptor antagonist, on the spontaneous and indomethacin- or methylene blue-induced constriction of the ductus arteriosus in rats. J Vet Med Sci 62:505-509.
147. Takizawa T, Kihara T, Kamata A. 2001. Increased constriction of the ductus arteriosus with combined administration of indomethacin and L-NAME in fetal rats. Biol Neonate 80:64-67.
148. Tanaka M, Miyakoshi K, Yamada M, et al. 2011. Functional foods for the fetus? Acta Obstet Gynecol Scand 90:1172-1173.
149. Tarcan A, Gurakan B, Yildirim S, et al. 2004. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure. J Perinat Med 32:98-99.
150. Toyoshima K, Momma K, Imamura S, Nakanishi T. 2006a. In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats. Biol Neonate 89:251-256.
151. Toyoshima K, Takeda A, Imamura S, et al. 2006b. Constriction of the ductus arteriosus by selective inhibition of cyclooxygenase-1 and -2 in near-term and preterm fetal rats. Prostaglandins Other Lipid Mediat 79:34-42.
152. Trevett TN Jr, Cotton J. 2004. Idiopathic constriction of the fetal ductus arteriosus. Ultrasound Obstet Gynecol 23:517-519.
153. Tulzer G, Gudmundsson S, Sharkey AM, et al. 1991. Doppler echocardiography of fetal ductus arteriosus constriction versus increased right ventricular output. J Am Coll Cardiol 18:532-536.
154. Turner GR, Levin DL. 1984. Prostaglandin synthesis inhibition in persistent pulmonary hypertension of the newborn. Clin Perinatol 11:581-589.
155. Tynan M. 1993. The ductus arteriosus and its closure. N Engl J Med 329:1570-1572.
156. USDA. 2007. Database for the flavonoid content of selected foods release. Available at: http://www.nal.usda.gov/fnic/foodcomp/Data/Flav/Flav02-1.pdf.
157. Valls-Pedret C, Lamuela-Raventos RM, Medina-Remon A, et al. 2012. Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk. J Alzheimers Dis 29:773-782.
158. van den Hoff MJ, Deprez RH, Ruijter JM, et al. 2004. Increased cardiac workload by closure of the ductus arteriosus leads to hypertrophy and apoptosis rather than to hyperplasia in the late fetal period. Naunyn Schmiedebergs Arch Pharmacol 370:193-202.
159. van der Graaf R, van Delden JJ. 2011. Equipoise should be amended, not abandoned. Clin Trials 8:408-416.
160. van der Graaf R, van Delden JJ. 2012. On what we will lose in giving up on clinical equipoise: a reply to Miller. Clin Trials 9:628-629.
161. Van Marter LJ, Hernandez-Diaz S, Werler MM, et al. 2013. Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn. Pediatrics 131:79-87.
162. Van Marter LJ, Leviton A, Allred EN, et al. 1996. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics 97:658-663.
163. Velioglu YS, Mazza G, Gao L, Oomah BD. 1998. Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products. J Agric Food Chem 46:4113-4117.
164. Vermillion ST, Scardo JA, Lashus AG, Wiles HB. 1997. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 177:256-259; discussion 259-261.
165. Vian I, Zielinsky P, Zilio AM, et al. 2013. Development and validation of a food frequency questionnaire for consumption of polyphenol-rich foods in pregnant women. Matern Child Nutr (Epub ahead of print).
166. Vogel M, Wilkins-Haug L, McElhinney DB, et al. 2010. Reversible ductus arteriosus constriction due to maternal indomethacin after fetal intervention for hypoplastic left heart syndrome with intact/restrictive atrial septum. Fetal Diagn Ther 27:40-45.
167. Walsh-Sukys MC. 1993. Persistent pulmonary hypertension of the newborn. The black box revisited. Clin Perinatol 20:127-143.
168. Wasserstrum N, Huhta JC, Mari G, et al. 1989. Betamethasone and the human fetal ductus arteriosus. Obstet Gynecol 74:897-900.
169. Widmer RJ, Freund MA, Flammer AJ, et al. 2013. Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis. Eur J Nutr 52:1223-1231.
170. Wilkinson AR, Aynsley-Green A, Mitchell MD. 1979. Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen. Arch Dis Child 54:942-945.
171. Wu GR, Jing S, Momma K, Nakanishi T. 2001. The effect of vitamin A on contraction of the ductus arteriosus in fetal rat. Pediatr Res 49:747-754.
172. Yajima I, Colombo S, Puig I, et al. 2013. A subpopulation of smooth muscle cells, derived from melanocyte-competent precursors, prevents patent ductus arteriosus. PLoS One 8:e53183.
173. Zhang G, Miura Y, Yagasaki K. 2000. Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity. Cancer Lett 159:169-173.
174. Zielinsky P, Bubols G, Piccoli AL, et al. 2012a. Experimental assessment of ductus arteriosus flow, oxidative stress and polyphenol excretion after maternal polyphenol-rich diet in late pregnancy. 22nd World Congress on Ultrasound in Obstetrics and Gynecology, 2012, Copenhagen-Ultrasound in Obstetrics & Gynecology (Print) 40:16.
175. Zielinsky P, Manica JL, Piccoli AL Jr, et al. 2007. Experimental study of the role of maternal consumption of green tea, mate tea and grape juice on fetal ductal constriction. 17th World Congress on Ultrasound in Obstetrics and Gynecology, 2007-Ultrasound in Obstetrics and Gynecology 30:515.
176. Zielinsky P, Manica JL, Piccoli AL Jr., et al. 2012b. Fetal ductal constriction caused by maternal ingestion of green tea in late pregnancy: an experimental study. Prenat Diagn 32:921-926.
177. Zielinsky P, Piccoli AL Jr, Manica JL, Nicoloso LH. 2010a. New insights on fetal ductal constriction: role of maternal ingestion of polyphenol-rich foods. Expert Rev Cardiovasc Ther 8:291-298.
178. Zielinsky P, Piccoli AL Jr, Manica JL, et al. 2010b. Maternal consumption of polyphenol-rich foods in late pregnancy and fetal ductus arteriosus flow dynamics. J Perinatol 30:17-21.
179. Zielinsky P, Piccoli AL Jr, Manica JL, et al. 2012c. Reversal of fetal ductal constriction after maternal restriction of polyphenol-rich foods: an open clinical trial. J Perinatol 32:574-579.
180. Zielinsky P, Piccoli AL Jr, Vian I, et al. 2013. Maternal restriction of polyphenols and fetal ductal dynamics in normal pregnancy: an open clinical trial. Arq Bras Cardiol 101:217-225.